We hope you are enjoying 340B Report’s new website and email platform that we launched yesterday. If you or a colleague did not receive the issue in your in-box, please make sure to mark us as a safe sender and add info@340breport.com to your contact list/allow list.

Starting close of business Eastern time tomorrow, most of 340B Report’s content including full articles will be available exclusively for paid subscribers. For those who have already paid, we sincerely thank you. Once we go behind a paywall, you will be prompted to log in to access the full content. If you have any questions, please contact Reshma Eggleston at reshma.eggleston@340Breport.com.

For those who have not made the investment in 340B Report, please subscribe today! Our 20 percent early bird discount ends on Jan. 31. If you have questions, please contact Reshma Eggleston at reshma.eggleston@340Breport.com.

340B Report is pleased to have a great group of sponsors for 2021. You will be learning more about these great companies over the coming weeks. Today’s issue includes a column by Jim Jorgenson on the top 10 pharmacy issues to consider in 2021. Jim is the CEO of Visante, one of our new sponsors.

Becoming a sponsor is a great way to promote your company to a targeted, highly engaged audience. Learn more about sponsorship benefits including free subscriptions here. Please contact 340B Report Publisher & CEO Ted Slafsky at ted.slafsky@340BReport.com if you would like a tour of the 2021 sponsorship packages.

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

*Sign up for news summaries and alerts from 340B Report